<?xml version="1.0" encoding="UTF-8"?>
<p id="para0015">On June 15, 2020, the US Food and Drug Administration (FDA) revoked chloroquine and hydroxychloroquine's emergency use authorization in response to the publication of new scientific data showing that these drugs are unlikely to be effective in treating COVID-19 [
 <xref rid="bib0017" ref-type="bibr">17</xref>,
 <xref rid="bib0018" ref-type="bibr">18</xref>]. In light of ongoing serious cardiac adverse events and other potential serious side effects, the potential benefits of chloroquine and hydroxychloroquine do not outweigh the risks of their use. The US Centers for Disease Control and Prevention has removed both drugs from its guidelines.
</p>
